The frequency of isolation of viridans streptococci from the blood of neutropenic patients with
cancer has significantly increased over the course of the last 10–15 years. Risk factors in …

Abstract Between 1988 and 1991, 26 episodes of bacteremia due to viridans streptococci
occurred in 25 neutropenic patients undergoing intensive chemotherapy for hematologic …

We prospectively studied 485 episodes of bacteremia in neutropenic patients with cancer.
Viridans streptococci caused a total of 88 episodes (18%). Ten (11%) of these 88 cases …

Viridans streptococci have long been considered, with the exception of the ability to cause
endocarditis, as minor pathogenic agents. More recently, however, these bacteria have …

We prospectively studied 260 episodes of bacteremia that occurred over a 6-year period in
neutropenic patients with cancer. Twenty-three episodes were caused by viridans …

Between 1972 and 1989, the incidence of viridans streptococcal bacteremia at the
University of Texas MD Anderson Cancer Center in Houston increased from one case per …

Viridans streptococci, a diverse group of streptococcal species, are important causes of
sepsis and pneumonia in the neutropenic host and sepsis and meningitis in the neonate …

ABSTRACT From January 1995 to May 1998, 57 episodes of bacteremia due to viridans
group streptococci were identified in 50 febrile neutropenic patients with hematologic …

Viridans streptococcal bacteraemia is frequent in neutropenic patients. 25 neutropenic
patients with viridans streptococcal bacteraemia were compared with 64 control patients …

Clinical and microbiologic studies of 50 cases of viridans streptococcal bacteremia in cancer
patients were performed. The bacteria were identified to species level by sequencing …